Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-12-046623)

Filing Details

Accession Number:: 0001209191-12-046623
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2012-09-25 14:39:42
Reporting Period:: 2012-07-30

Filing Date:: 2012-09-25
Accepted Time:: 2012-09-25 14:39:42
Original Submission Date:: 2012-08-01
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1411158	Anacor Pharmaceuticals Inc	ANAC	Pharmaceutical Preparations (2834)	251854385

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1504466	R Kirk Maples	C/O Anacor Pharmaceuticals, Inc. 1020 East Meadow Circle Palo Alto CA 94303	Svp, Program Management	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2012-07-30	3,000	$6.03	15,652	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

This is NOT a new sale transaction - this is an amendment is SOLELY for the purpose of adding a Power of Attorney (Written Authorization - authority of person signing). All other information remains the same and correct, as filed on7/30/12.